Bixiye
Kerendia® - Commercial - Effective Date 03/01/2025
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 1781 - 1790 ee natiijooyinka 3688
Bixiye
Interstitial Lung Disease (ILD) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Interleukin-5 (IL-5) Inhibitors - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Arikayce® (amikacin liposome inhalation) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Antifungals - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2024
Bixiye
Antifungals - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
QP32-22 Commercial Pharmacy Benefit Exclusion for EnjaymoTM
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Bixiye
QP33-22 MHCP Pharmacy Benefit Exclusion for CarvyktiTM and EnjaymoTM
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Bixiye
QP34-22 Minnesota Senior Health Options (MSHO) Model of Care: Annual Training Requirement Reminder
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Bixiye
QP35-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 14, 2022
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022